Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Idioma
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Zhong Yao Cai ; 37(2): 293-8, 2014 Feb.
Artigo em Zh | MEDLINE | ID: mdl-25095354

RESUMO

OBJECTIVE: To research pharmacodynamic effect of Yangganjiejiu prescription on alcoholic fatty liver and its mechanism. METHODS: The alcoholic fatty liver models of rats was set up by feeding high fat diet and alcohol. Sixty male SD rats were randomly divided into 6 groups: normal group, model group, low-dose Yangganjiejiu prescription group (0.7 g/kg), medial-dose group (1.4 g/kg), high-dose group (2.8 g/kg) and positive control drug Dongbao Gantai group, 10 rats were in each group. RESULTS: Yangganjiejiu prescription (1.4 and 2.8 g/kg) could significantly reduce alcoholic fatty liver rats' serum and liver tissues of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol( LDL-C) levels (compared with the model group, P < 0.05) and lower serum free fatty acids (FFA) content (compared with the model group, P < 0.05), and to some extent increase the serum and liver tissues of high-density lipoprotein (HDL-C) levels (but compared with the model group, there was no statistical significance, P > 0.05); It could improve liver function, lower serum AST, ALP and GGT content (compared with the model group, P < 0.05 or P < 0.01), significantly decrease serum and liver tissue MDA (P < 0.01), increase SOD in serum and liver tissue (P < 0.01), alleviate alcoholic fatty on the liver secondary liver pathology, and reduce fatty liver. CONCLUSION: Yangganjiejiu prescription has preventive and therapeutic effect on alcoholic fatty liver. Its mechanism is closely related to resistance to oxidative damage, reducing blood lipid, protecting liver and lowering transaminase.


Assuntos
Antioxidantes/uso terapêutico , Medicamentos de Ervas Chinesas/uso terapêutico , Fígado Gorduroso Alcoólico/tratamento farmacológico , Hipolipemiantes/uso terapêutico , Alanina Transaminase/sangue , Animais , Antioxidantes/farmacologia , Dieta Hiperlipídica/efeitos adversos , Modelos Animais de Doenças , Combinação de Medicamentos , Medicamentos de Ervas Chinesas/farmacologia , Fígado Gorduroso Alcoólico/metabolismo , Hipolipemiantes/farmacologia , Lipídeos/sangue , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Testes de Função Hepática , Masculino , Malondialdeído/sangue , Plantas Medicinais/química , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Superóxido Dismutase/sangue
2.
Zhong Yao Cai ; 36(9): 1486-9, 2013 Sep.
Artigo em Zh | MEDLINE | ID: mdl-24620698

RESUMO

OBJECTIVE: To investigate the effect of Jianpihuashi Decoction on rats with hyperuricemia. METHODS: Forty male Sprague-Dawley (SD) rats were randomly divided into four groups: normal, hyperuricemia, Jianpihuashi Decoction and Allopurinol group. After the administration for 0 day, 10 days, 20 days and 30 days, the serum uric acid, creatinine, urea nitrogen and xanthine oxidase (XOD) activity levels were separately detected using the orbital blood. 30 days after the experiment, the rats were anaesthetized by 3% pentobarbital sodium, liver tissue homogenate extracts were used to detect the XOD activity, and histopathological changes in kidney were observed by HE staining. RESULTS: Treatment with Jianpihuashi Decoction for 30 days, the serum uric acid level of rats with hyperuricemia were significantly decreased (P < 0.05). Simultaneously, the XOD activity in the serum and liver tissue homogenate extracts were obviously decreased by the decoction, which had seldom toxic or side effects on kidney. Allopurinol group could significantly decrease the serum uric acid level, but it had seldom pathological injury to kidney at the same time. CONCLUSION: Jianpihuashi Decoction which has seldom pathological injury to kidney can significantly decrease the effect of uric acid by suppressing XOD activity.


Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Hiperuricemia/tratamento farmacológico , Fígado/metabolismo , Ácido Úrico/sangue , Xantina Oxidase/metabolismo , Alopurinol/farmacologia , Alopurinol/uso terapêutico , Animais , Nitrogênio da Ureia Sanguínea , Creatinina/sangue , Modelos Animais de Doenças , Combinação de Medicamentos , Medicamentos de Ervas Chinesas/farmacologia , Hiperuricemia/sangue , Hiperuricemia/metabolismo , Rim/efeitos dos fármacos , Rim/patologia , Fígado/efeitos dos fármacos , Masculino , Ácido Oxônico/administração & dosagem , Plantas Medicinais/química , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Uricosúricos/farmacologia , Uricosúricos/uso terapêutico , Xantina Oxidase/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA